The present disclosure relates to methods and compositions comprising naturally occurring light absorbing molecules for preventing damages from light exposure. Specific embodiments of this disclosure include fluorescent proteins from Brachiostoma lanceolatum.

Disclosed are cosmetic formulation comprising (a) particulates having an absorption in the range of 400 to 800 nm; and (b) UV filters selected from (b.sub.1) particulate organic UV-filters; and (b.sub.2) soluble organic UV filters.

An in vitro method for demonstrating the stain removal efficacy of an oral care composition comprising (a) providing a substrate, (b) providing a staining solution, (c) providing a treatment solution comprising the oral care composition, (d) immersing the substrate in the staining solution, (e) removing the substrate from the staining solution, (f) evaluating the color of the stained substrate, (g) applying the treatment solution to the substrate and (h) evaluating the color of the treated substrate, wherein the staining solution comprises coffee is provided.

A dermatological and/or topical composition, which contains retinaldehyde, and DNA.

The present invention relates to a non-therapeutic cosmetic method—for enhancing the overall quality of the skin and for treating aging skin which comprises the use of non-hydrolyzed nucleic acid material extracted from tuna containing more than 75% by weight of DNA salts and less than 1.5 wt % of proteins, and to a non-therapeutic cosmetic composition for topical application onto the skin comprising from 0.01 to 5.0% by weight of said non-hydrolyzed nucleic acid material in a cosmetic or pharmaceutical acceptable carrier.

Provided is a structural protein microbody that functions as a core for forming a protein nanofiber. There is provided a structural protein microbody including a structural protein, in which the structural protein microbody satisfies at least two of the following (i) to (iii): (i) a peak is present within a range of 480 to 500 nm in a fluorescence intensity measurement by thioflavin T staining; (ii) a peak is present in a region where Q is 0.15 or less in a modified Kratky plot of small angle X-ray scattering (SAXS); and (iii) the structural protein microbody is an aggregate of two or more structural protein molecules.

A cosmetic composition including, in a continuous aqueous phase, at least one leguminous starch having an amylose content greater than or equal to 30%, at least one plasticiser selected from polyols and at least one hydrophilic gelling agent selected from xanthan gum, sclerotium gum, and the mixture thereof. Also, the use of such a composition for forming, on keratinous materials, a sweat and sebum resistant film.

It is described a process, starting from fishbones, for the production of a material having properties of physical type solar filter and photoprotective boosting agent, formed by particles of hydroxyapatite or hydroxyapatite substituted with metal ions, optionally mixed with calcium triphosphate and with metal oxides. Are also described the material obtained through the process and cosmetic or plant sunscreen compositions that comprise said material.

A freeze-dried formulation and a preparation method and an application thereof are provided. Triterpenoid saponin has a mass percentage of 0.004-95% in the freeze-dried formulation, a binding agent has a mass percentage of 0.01-99% in the freeze-dried formulation; the freeze-dried formulation is freeze-dried by a primary prepared solution containing the triterpenoid saponin and the binding agent; when the triterpenoid saponin has a mass percentage of 0.001%-50% in the primary prepared solution, the binding agent has a mass percentage of 0.01%-50% in the primary prepared solution, and a mass of the triterpenoid saponin increases with an increase of a mass of the binding agent; and when the triterpenoid saponin has a mass percentage of 50%-95% in the primary prepared solution, the binding agent has a mass percentage of 0.01%-20% in the primary prepared solution, and the mass of triterpenoid saponin decreases with the increase of the mass of the binding agent.

The present disclosure relates to the treatment of a skin condition in a subject, including but not limited to one or more of luminosity, brightness, skin pore size, skin pore count, sebum production, sebum composition, overall skin quality, eyelid laxity, fine lines under the eye, fine lines on the face, laxity on the face, perioral rhytids, moderate to severe facial folds and wrinkles such as nasolabial folds, moderate to severe facial wrinkles such as smile lines or marionette lines, age-related midface contour deficiencies, dorsal hand to correct volume deficit, glabellar lines, correction of facila depressions, either due to injury or age-related, perioral wrinkles, lip commissures, crow's feet, facial rhytides, and forehead wrinkles, comprising applying to the skin of the subject a first composition derived from one or more sponges, and a second composition comprising one or more botulinum toxins. Also provided are compositions for use in the treatment of a skin condition in a subject, including but not limited to hyperhidrosis, comprising a first composition and a second composition, wherein (a) the first composition comprises Spongilla; and (b) the second composition comprises one or more botulinum toxins. Also provided are kits, including kits for the treatment of a skin condition in a subject including but not limited to hyperhidrosis, comprising a first composition and a second composition, wherein the first composition comprises Spongilla, and the second composition comprises one or more botulinum toxins.